Evolva announced that it has completed a Limited Purpose Cooperative Research and Development Agreement (CRADA) to support the joint development of novel advanced materials with the US...
Evolva announces that it is expanding its current work with the US Centers for Disease Control (CDC) to research nootkatone’s effectiveness in tick-control to include an...
